Document:

Index License Agreement

 Exhibit 10.7 
 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been
filed separately with the Securities and Exchange Commission. 
 INDEX LICENSE AGREEMENT 
 Between 
 DOW JONES &
COMPANY, INC. 
 And 
 THE BOARD OF TRADE OF THE CITY OF CHICAGO, INC. 
 Effective: September 11, 2007 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities
and Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
 Table of Contents 
  

							
	 ARTICLE I – DEFINITIONS; INTERPRETATION
	  	1
		  	1.	  	Definitions	  	1
		  	2.	  	Interpretation	  	4
		
	ARTICLE II – TERMS AND CONDITIONS	  	5
		  	1.	  	Grant of License.	  	5
		  	2.	  	Term.	  	7
		  	3.	  	License Fees.	  	7
		  	4.	  	Termination.	  	8
		  	5.	  	Dow Jones Obligations: Licensee’s Obligations.	  	10
		  	6.	  	Intellectual Property.	  	11
		  	7.	  	Proprietary Rights.	  	14
		  	8.	  	Warranties: Disclaimers.	  	15
		  	9.	  	Indemnification.	  	16
		  	10.	  	Suspension of Performance.	  	17
		  	11.	  	Injunctive Relief.	  	17
		  	12.	  	Other Matters.	  	17
		
	INDEX OF ATTACHMENTS	  	21
		  	SCHEDULE A. LICENSED INDEXES	  	22
		  	SCHEDULE B. DOW JONES MARKS	  	23
		  	SCHEDULE C. LICENSE FEES	  	24
		  	SCHEDULE D. DISCLAIMER	  	26
		  	SCHEDULE E. SUBLICENSE	  	27
	SUBLICENSEE	  	28

  

 i 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 INDEX OF ATTACHMENTS 
 SCHEDULES: 
  

			
	Schedule A	  	Licensed Indexes
	Schedule B	  	Licensed Marks
	Schedule C	  	License Fees
	Schedule D	  	Disclaimer
	Schedule E	  	Draft Sublicense

  

 ii 

 This Agreement (“Agreement”), dated as of September 11, 2007 (the “Effective
Date”), is made by and between Dow Jones & Company, Inc. (“Dow Jones”), having an office at 200 Liberty Street, New York, New York 10281, and the Board of Trade of the City of Chicago, Inc. (the “Licensee”), having
an office at 141 West Jackson Boulevard, Chicago, Illinois 60604. 
 WHEREAS, Dow Jones compiles, calculates and maintains the indexes
specified on Schedule A hereto (the “Licensed Indexes”), and Dow Jones owns rights in and to the Licensed Indexes, the proprietary data contained therein, and the Dow Jones Marks (defined below) (such rights, including without limitation,
copyright, patents, database rights, trademark and service marks and the goodwill associated therewith, proprietary rights and trade secrets, such rights being hereinafter collectively referred to as the “Intellectual Property”) and

 WHEREAS, Dow Jones uses in commerce and has trade name and/or trademark rights to certain designations defined in Schedule C and those
designations identifying the indexes listed on Schedule A hereto (such rights being hereinafter individually and collectively referred to as the “Dow Jones Marks”) and 
 WHEREAS, Dow Jones and License are currently parties to a Agreement (inclusive of all amendments referred to as the “1997 Agreement “), which
will expire on December 31, 2007 pursuant to which Licensee uses certain of the Licensed Indexes and the Dow Jones Marks in connection with (i) the listing for trading, marketing and promotion of the Products and (ii) making
disclosure about the Products under applicable laws, rules and regulations in order to indicate that Dow Jones is the source of the Licensed Indexes. 
 WHEREAS, Dow Jones and Licensee wish to enter into a new licensing arrangement by entering into this Agreement pursuant to the terms and conditions hereinafter set forth; 
 NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein, it is agreed as follows: 
 ARTICLE I – DEFINITIONS; INTERPRETATION 
  

	1.	Definitions 

 The following words and phrases have the following
meanings for purposes of this Agreement. 
  

	 	1.1	“1997 Agreement” has the meaning set forth in the Recitals to this Agreement. 

  

	 	1.2	“Agreement” has the meaning set forth in the Recitals to this Agreement. 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	1.3	“Breaching Party” means a party who materially breaches this Agreement. 

  

	 	1.4	“CBOT” means the Board of Trade of the City of Chicago, Inc. 

  

	 	1.5	“CFTC” means United States Commodity Futures Trading Commission. 

  

	 	1.6	“Change in the Law” has the meaning set forth in Article II, Section 6.8. 

  

	 	1.7	“Confidential Information” means (i) any documentation or other materials that are marked as “Confidential” by the providing party, (ii) information
that is disclosed orally and is indicated as “Confidential” at the time of disclosure or ought reasonably to be considered confidential under the circumstances and (iii) the terms of this Agreement. Confidential Information as
described in clause (i) of the preceding sentence shall not include (A) any information that is available to the public or to the receiving party hereunder from sources other than the providing party (provided that such source is not
subject to a confidentiality agreement with regard to such information) or (B) any information that is independently developed by the receiving party without use of or reference to Confidential Information from the providing party.

  

	 	1.8	“Control” means ownership of more than fifty percent (50%) of the voting securities. 

  

	 	1.9	“DJIA” means the Dow Jones Industrial Average index. 

  

	 	1.10	“Dow Jones Marks” has the meaning set forth in the Recitals to this Agreement. 

  

	 	1.11	“Dow Jones” means Dow Jones & Company, Inc. 

  

	 	1.12	“Effective Date” has the meaning set forth in the preamble to this Agreement. 

  

	 	1.13	“Exclusively Licensed Indexes” has the meaning set forth in Schedule A to this Agreement. 

  

	 	1.14	“Exclusive Products” has the meaning set forth in Schedule C. 

  

	 	1.15	“Informational Materials” means, collectively, informational materials to be used in connection with the Products (including, when applicable, press releases,
advertisements, brochures, flyers, handouts, web pages, and promotional and any other similar informational materials, and any documents or materials required to be filed with governmental or regulatory agencies) that in any way use or refer to Dow
Jones, any of the Licensed Indexes or any of the Dow Jones Marks. 

  

 2 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	1.16	“Initial Term” means the initial contract period of time beginning on January 1, 2008 through December 31, 2014. 

  

	 	1.17	“Intellectual Property” has the meaning set forth in the Recitals to this Agreement. 

  

	 	1.18	“ISE Litigation” has the meaning set forth in Article II, Section 4.3. 

  

	 	1.19	“License Fees” means the fees payable by Licensee to Dow Jones under this Agreement. 

  

	 	1.20	“Licensed Indexes” has the meaning set forth in the Recitals to this Agreement. 

  

	 	1.21	“Licensee” has the meaning set forth in the Recitals to this Agreement. 

  

	 	1.22	“Losses” has the meaning set forth in section 9.1 of this Agreement. 

  

	 	1.23	“Market Data” shall mean bids, asks and market prices, opening and closing range prices, high-low prices, settlement prices, estimated and actual contract volume and other
information regarding Licensee’s market activity, including exchange for physical transactions (excluding the values (e.g., index symbol, close, net change, net % change, open, high, low, etc.) of the Licensed Indexes).

  

	 	1.24	“Non-exclusively Licensed Indexes” has the meaning set forth in Schedule A to this Agreement. 

  

	 	1.25	“Non-breaching Party” has the meaning set forth in Article II, Section 4.1. 

  

	 	1.26	“Pending Products” means Products that are listed by Licensee when this Agreement is terminated. 

  

	 	1.27	“Per Contract Fees” has the meaning set forth in Schedule C. 

  

	 	1.28	“Products” means standardized futures contracts and options on futures contracts that are traded on an exchange and based upon one or more of the Licensed Indexes and that
are to be traded on or through the Licensee. Products shall be based on the whole Index and not any subset of or any of the components of any Index. Contracts for difference (CFDs) and spread betting are not Products for the purposes of this
Agreement. Products may be quoted as described in Article II, Section 1.9. 

  

	 	1.29	“Proposed Index” means an index that Licensee may propose to Dow Jones to provide from time to time. 

  

 3 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	1.30	“Quarterly Minimum” has the meaning set forth in Schedule C. 

  

	 	1.31	“Renewal Term(s)” means the period(s) of time after the Initial Term during which this agreement is in force. 

  

	 	1.32	“Sublicense Agreement” has the meaning set forth in Article II, Section 1.10. 

  

	 	1.33	“Suspension Period” has the meaning set forth in Article II, Section 6.8 and 6.9. 

  

	 	1.34	“Target Launch Date” has the meaning set forth in Schedule A. 

  

	 	1.35	“Term” means the Initial Term and any Renewal Terms. 

  

	 	1.36	“Unlicensed User” means an exchange that uses one or more of the Exclusively Licensed Indexes or related Dow Jones Marks in connection with Products without the prior
written consent of Licensee and Dow Jones. 

  

	2.	Interpretation 

  

	 	2.1	The term “include” (in all its forms) means “include, without limitation” unless the context clearly states otherwise. 

  

	 	2.2	All references in this Agreement to Articles, Sections, Schedules and Attachments, unless otherwise expressed or indicated are to the Articles, Sections, Schedules and Attachments
of this Agreement. 

  

	 	2.3	Words importing persons include firms, associations, partnerships, trusts, corporations and other legal entities, including public bodies, as well as natural persons.

  

	 	2.4	Any headings preceding the text of the Articles and Sections of this Agreement and any table of contents or marginal notes appended to it, are solely for convenience or reference
and do not constitute a part of this Agreement, nor do they affect the meaning, construction or effect of this Agreement. 

  

	 	2.5	Words importing the singular include the plural and vice versa. 

  

	 	2.6	All references to a number of days mean calendar days, unless expressly indicated otherwise. 

  

	 	2.7	All references to “reasonable efforts” shall include taking into account all relevant commercial and regulatory factors. 

  

 4 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	2.8	All references to “regulation” or “regulatory proceedings” shall include regulations or proceedings by self-regulatory organizations such as securities or
futures exchanges. 

 ARTICLE II – TERMS AND CONDITIONS 
  

	1.	Grant of License. 

  

	 	1.1	Subject to the terms and conditions of this Agreement, during the Term of this Agreement, Dow Jones hereby grants to Licensee a non-transferable sole and exclusive license on a
worldwide 24-hour basis to use and, with the prior written consent of Dow Jones or pursuant to Article II, Section 1.10, to sublicense the Exclusively Licensed Indexes solely in connection with creating, listing, trading, clearing, marketing,
and promoting the Products. Dow Jones shall not grant a license to any person in contravention of this Article II, Section 1.1. 

  

	 	1.2	Subject to the terms and conditions of this Agreement, during the Term of this Agreement , Dow Jones hereby grants to Licensee a non-transferable non-exclusive license on a
worldwide 24-hour basis to use the Non-exclusively Licensed Indexes solely in connection with creating, listing, trading, clearing, marketing, and promoting the Products; provided, however, Dow Jones reserves the right to terminate the foregoing
license with respect to individual Non-exclusively Licensed Indexes upon written notice to Licensee if Licensee has not commenced trading a Product based on such Non-exclusive Index(es) by the applicable Target Launch Date identified in Schedule A.

  

	 	1.3	Subject to the terms and conditions of this Agreement, during the Term of this Agreement , Dow Jones hereby grants to Licensee a non-transferable license to use and refer to and,
with the prior written consent of Dow Jones or pursuant to Article II, Section 1.10, to sublicense the Dow Jones Marks in connection with Licensee’s creating, listing, trading, clearing, marketing, and promoting the Products in order to
indicate the source of the Licensed Indexes and as may otherwise be required by applicable laws, rules or regulations or under this Agreement . 

  

	 	1.4	 Prior to December 31, 2010, Dow Jones shall not grant a license to use a “Dow Jones” branded index (e.g., not a co-branded index) based in whole on
U.S. equities that is developed by Dow Jones on or after the Effective Date for any futures contract or option on a futures contract traded on an exchange, board of trade of other entity regulated by the CFTC, to any third party unless Dow Jones has
first offered in writing to license such index to Licensee. If Licensee responds in writing to Dow Jones’ offer within thirty (30) days, Dow Jones and Licensee shall negotiate in good 

  

 5 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
faith, exercising reasonable efforts to agree on the terms of such license. If Licensee does not respond in writing to Dow Jones’ offer within thirty
(30) days of its receipt, or if Dow Jones and Licensee have not executed a written agreement granting such a license to Licensee with the Product having been launched within thirty (30) days after Licensee’s initial response, then Dow
Jones may license such index to any other third party; provided that the terms of any such license granted shall not be more favorable than those offered to or negotiated with Licensee. 

  

	 	1.5	Nothing contained in this Agreement constitutes a license to the Licensee to use any one or more of the Licensed Indexes other than in connection with the creating, listing,
trading, clearing, marketing, and promoting the Products. 

  

	 	1.6	The Licensee acknowledges that the Licensed Indexes and the Dow Jones Marks are the exclusive property of Dow Jones and that Dow Jones has and retains all Intellectual Property and
other proprietary rights therein. Except as otherwise specifically provided herein, Dow Jones reserves all rights to the Licensed Indexes and the Dow Jones Marks, and this Agreement shall not be construed to transfer to the Licensee any ownership
right to, or equity interest in, the Licensed Indexes or the Dow Jones Marks, or in any Intellectual Property or other proprietary rights pertaining thereto. 

  

	 	1.7	The Licensee acknowledges that the Licensed Indexes and their compilation and composition, and any changes therein, are and will be in the complete control and sole discretion of
Dow Jones. 

  

	 	1.8	Aside from the limitations set forth in the scope of the licenses granted herein and Dow Jones’ limited approval rights provided below, there will be no restrictions placed on
how Licensee structures Products or how Licensee offers Products for trading. For example, Licensee may facilitate spread trading among Products and other products through special quoting or pricing mechanisms. For the avoidance of doubt, Licensee
may continue to offer Products for trading through any trading or quoting mechanism that Licensee offers as of the Effective Date, including quoting based on volatility. If spread trading results in multiple Products being traded and Licensee
collecting fees for those Products, Licensee shall pay Dow Jones the License Fees for each of those Products as if each Product had traded separately. If Licensee lists a spread product reflecting an interest in multiple Products as a separate
instrument such that one Product is traded and Licensee collects fees for one Product, Licensee shall pay Dow Jones a license fee for one Product at the ***** rate that would apply to any included Product. 

  

 6 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	1.9	Licensee may list Products of various contract sizes based on a Licensed Index. As of the Effective Date, Licensee may list a Product based on the Dow Jones Industrial Average with
a contract size of approximately ten (10) times the value of the DJIA and a different Product with a contract size of approximately five (5) times the value of the DJIA. Any new contract size shall be subject to Dow Jones’ prior
approval, which approval shall not be unreasonably withheld. 

  

	 	1.10	Notwithstanding any other provision of this Agreement, Dow Jones grants Licensee the right to sublicense its rights with respect to the Exclusively Licensed Indexes and the Dow
Jones Marks that designate such indexes to any other exchange for use with Products subject to such exchange executing a Sublicense Agreement substantially in the form attached as Schedule E (a “Sublicense Agreement”).

  

	 	1.11	Subject only to Article II, Section 1.1, nothing contained in this Agreement shall restrict Dow Jones from licensing any one or more of the Licensed Indexes or the Dow Jones
Marks to any other person or entity at any time. 

  

	 	1.12	Notwithstanding any other provision of this Agreement, Dow Jones shall not grant a license to any third party to use the Exclusively Licensed Indexes and related Dow Jones Marks as
the basis of exchange-traded or OTC contracts for difference or spread betting traded in the United States unless (a) Dow Jones has first obtained Licensee’s prior written consent, which consent shall not be unreasonably withheld and
(b) Dow Jones and Licensee ***** received in connection with such license as mutually agreed. 

  

	2.	Term. 

 The Initial Term of this Agreement shall commence
January 1, 2008 and continue through December 31, 2014. This Agreement shall automatically renew for a first renewal term of five (5) years and for successive annual renewal terms thereafter (collectively “Renewal Terms”)
unless either Party gives written notice of non-renewal to the other Party at least six (6) months prior to the end of the Initial Term or then-current Renewal Term, or this Agreement is otherwise terminated earlier as provided herein.
Notwithstanding the Term, the Agreement shall be binding on the parties as of the Effective Date. 
  

 7 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	3.	License Fees. 

  

	 	3.1	As consideration for the license granted herein, the Licensee shall pay to Dow Jones or the Dow Jones affiliate designated by Dow Jones the License Fees as set forth on Schedule C
hereto. 

  

	 	3.2	Dow Jones shall have the right to audit on a confidential basis the relevant books and records of the Licensee to confirm the accuracy of any one or more calculations of License
Fees. Dow Jones shall bear its own costs of any such audit unless it is determined that Dow Jones has been underpaid by 5% or more with respect to the payments being audited, in which case Dow Jones’ costs of such audit shall be paid by the
Licensee. 

  

	 	3.3	As consideration for entry into this License Agreement, Licensee shall pay Dow Jones an upfront fee of $***** payable in full as of January 1, 2008. Dow Jones shall issue an
invoice, which Licensee shall pay within thirty (30) days of the date thereof. If Licensee is obligated to make a Hart-Scott-Rodino filing and as a result the exclusive license granted herein is significantly curtailed or limited, either party
may terminate the License Agreement upon written notice to the other within ninety (90) days of such ruling and, in connection with such termination, Dow Jones shall refund the $***** upfront fee. 

  

	 	3.4	For the avoidance of doubt, the upfront fee and the License Fees shall be deemed “Confidential Information” under this Agreement. 

  

	4.	Termination. 

  

	 	4.1	If either party (“Breaching Party”) materially breaches this Agreement, then the other party (“Non-breaching Party”) may terminate this Agreement, effective
thirty (30) days after written notice thereof to the other party (with reasonable specificity as to the nature of the breach and including a statement as to such party’s intent to terminate), unless the Breaching Party shall correct such
breach within such 30-day period. 

  

	 	4.2	 The Licensee or Dow Jones may terminate this Agreement with respect to any one or more specific Indexes (but not the Agreement in its entirety) upon ninety
(90) days prior written notice to the other (or such lesser period of time as may be necessary pursuant to law, rule, regulation or court order) if (i) any legislation or regulation is finally adopted or any government interpretation is
issued that prevents the Licensee from listing for trading, marketing or promoting such Product; (ii) any material litigation or material regulatory proceeding regarding a Product based on such a Licensed Index is commenced and such party
reasonably believes that such litigation or regulatory proceeding is reasonably likely to have a material and adverse effect on the good name or reputation of such party. Licensee reserves the right to de-list any Product based on a Licensed Index
at any time; provided, however, any such delisting shall not give 

  

 8 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
rise to a termination right with respect to this Agreement. The parties to this Agreement agree that the pending litigation between CBOE, S&P, Dow Jones
and the International Securities Exchange (the “ISE Litigation”), would not trigger a right to terminate under this section 4.2. 

  

	 	4.3	Dow Jones may terminate this Agreement upon ninety (90) days prior written notice to the Licensee (or such lesser period of time as may be necessary pursuant to law, rule,
regulation or court order) if (i) any legislation or regulation is finally adopted or any government interpretation is issued that in Dow Jones’ reasonable judgment materially impairs Dow Jones’ ability to license and provide the
Licensed Indexes or the Dow Jones Marks under this Agreement; (ii) any litigation or proceeding is commenced which relates, directly or indirectly, to Dow Jones licensing and providing the Licensed Indexes or the Dow Jones Marks under this
Agreement, or any such litigation proceeding is threatened and Dow Jones reasonably believes that such litigation or proceeding would be reasonably likely to have a material and adverse effect on the Licensed Indexes or the Dow Jones Marks or on Dow
Jones’ ability to perform under this Agreement; or (iii) any material litigation or material regulatory proceeding regarding a Product based on an Index is commenced and Dow Jones reasonably believes that such litigation or regulatory
proceeding is reasonably likely to have a material and adverse effect on the good name or reputation of Dow Jones. The parties to this Agreement agree that the ISE Litigation would not trigger the right to terminate under this section 4.3.

  

	 	4.4	Dow Jones may terminate this Agreement upon written notice to the Licensee if any securities exchange ceases to provide data to Dow Jones necessary for providing all of the Licensed
Indexes, terminates Dow Jones’ right to receive data in the form of a “feed” from such securities exchange, materially restricts Dow Jones right to redistribute data received from such securities exchange, or institutes charges of a
type or to an extent applicable to Dow Jones (and not to others generally) for the provision of data to Dow Jones or the redistribution of data by Dow Jones. If such cessation restricts Dow Jones’ ability to met its obligations of only a subset
of the Licensed Indexes, then Dow Jones’ right terminate under this Section 4.4 shall apply only to such subset of the Licensed Indexes and not the Agreement in its entirety. 

  

	 	4.5	Notwithstanding anything to the contrary herein, in the event that there shall occur any change in law (statutory law, case law or otherwise) relating to or affecting the liability
of index providers to third parties, and Dow Jones thereafter ceases to engage in the business of providing real-time data with respect to indexes or licensing real-time indexes as the basis of Products, Dow Jones shall have the right to terminate
this Agreement upon written notice to the Licensee. 

  

 9 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	4.6	Notwithstanding anything to the contrary herein, Dow Jones shall have the right, in its sole discretion, to cease compiling, calculating and publishing values of any one or more of
the Licensed Indexes, and to terminate this Agreement with respect only to such Indexes, at any time that Dow Jones determines such Indexes no longer meet or will not be capable of meeting the criteria established by Dow Jones for maintaining such
Indexes (and in such event Dow Jones will use all reasonable efforts to provide Licensee as much prior notice as is reasonably practicable under the circumstances). 

  

	 	4.7	In the event either the Licensee or Dow Jones shall give proper notice of termination pursuant to this Section 4 (but excluding Section 4.6), any Pending Products may
continue to be traded to the expiration date thereof, and (i) to the extent necessary for such purpose, the license granted in Article II, Sections 1.1-1.3 and Dow Jones’ obligations under Article II, Sections 5.2 and 7, and (ii) the
Licensee’s obligations under Article II, Sections 6, 7, 8.2 shall be deemed to continue until the expiration date of the last of such Pending Products. Notwithstanding the above, any Pending Products without open interest which are farther out
than the farthest contract month with open interest shall be terminated. Notwithstanding the above, in the event of a termination by Dow Jones under Section 4.1 by reason of any breach by the Licensee relating to its obligations under this
Agreement with respect to Dow Jones’ Intellectual Property, Section 6.7 shall continue to apply to the Licensee. Notwithstanding the foregoing, in the event of a termination by reason of discontinuance of any Licensed Index under Sections
4.4, 4.5 or 4.6, Dow Jones shall, at the time the notice of termination is provided to the Licensee, provide to the Licensee a non-exclusive, perpetual and royalty-free license effective as of the date of the discontinuance and a list of companies,
shares outstanding and divisors for the terminated Licensed Index as of the date of discontinuance. The Licensee shall not thereafter make any reference to the Dow Jones Marks in respect of the discontinued Licensed Index (except as provided in the
next sentence) and Dow Jones shall have no further obligations to the Licensee with respect to the discontinued Licensed Index, or any Product based thereon, after furnishing the Licensee with the aforesaid information. In any such event, the
Licensee shall redesignate the Licensed Index and the Products based thereon without the use of any of the Dow Jones Marks and may continue to list for trading Pending Products as if no notice of termination had been received, except that, until
termination of the license, such index shall be described as the “             Index” formerly “Dow Jones
             Index”. Thereafter, upon termination of the license, the Licensee may promote and list for trading indexed products based upon the securities index designated by
the name “             Index” or equivalent provided that the Licensee prominently disclaims any relationship with Dow Jones in respect thereto. 

 

 10 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	5.	Dow Jones Obligations: Licensee’s Obligations. 

  

	5.1	Dow Jones is not, and shall not be, obligated to engage in any way or to any extent in any marketing or promotional activities in connection with the Products or in making any
representation or statement to investors or prospective investors in connection with the marketing or promotion of the Products by the Licensee. At the Licensee’s request, Dow Jones will provide Licensee with all reasonable cooperation in
connection with Licensee obtaining and maintaining regulatory approval for the Products. 

  

	5.2	Dow Jones agrees to provide reasonable support for the Licensee’s development and educational efforts with respect to the Products as follows: 

  

	 	5.2.1	Dow Jones shall respond in a timely fashion to any reasonable requests by the Licensee for information regarding the Licensed Indexes. 

  

	 	5.2.2	Dow Jones or its agent shall, or Dow Jones shall arrange for a third party vendor to, calculate, and provide to the Licensee via a feed the values of each of the Licensed Indexes at
least once every fifteen (15) seconds, or more frequently if agreed by the parties, on each day that the New York Stock Exchange (or the applicable exchange from which such Index is derived) is open for trading, in accordance with Dow
Jones’ current procedures, which procedures may be modified by Dow Jones. 

  

	 	5.2.3	Dow Jones shall promptly correct, or instruct its agent to correct, any mathematical errors made in Dow Jones’ computations of the Licensed Indexes of which Dow Jones becomes
aware in accordance with Dow Jones Indexes’ then-current data correction policy. 

  

	5.3	Dow Jones shall use reasonable efforts to safeguard the confidentiality of all impending changes in the components or method of computation of the Licensed Indexes until such
changes are publicly disseminated, and shall require the same of any agent with whom it has contracted for computation thereof. Dow Jones shall implement reasonable procedures so that only those persons at Dow Jones directly responsible for changes
in the composition or method of computation of the Licensed Indexes shall be granted access to information respecting impending changes. 

  

	5.4	Notwithstanding anything herein to the contrary, nothing in this Section 5 shall give the Licensee the right to exercise any judgment or require any changes with respect
to Dow Jones’ method of composing, calculating or determining the Licensed Indexes. Nothing in this Section 5 shall be deemed to modify the provisions of Section 9 of this Agreement. 

  

	5.5	 Throughout the Term, the Licensee and any Affiliate exercising rights under this Agreement, shall maintain, as part of its rules, to be set forth in the terms of
the Products and in Licensee’s or such Affiliate’s Rules or Regulations, a limitation of 

  

 11 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
liability of licensors of indexes, with respect to trading on or through the Licensee, which is in the form and substance substantially as set forth in
CBOT’s Rule Book as of the Effective Date. 

  

	6.	Intellectual Property. 

  

	6.1	During the Term, Dow Jones shall use its best efforts to maintain in full force and effect U.S. federal registrations of the “Dow Jones”, “DJIA” and “The
Dow” service marks. The Licensee shall reasonably cooperate with Dow Jones in the maintenance of such rights and registrations and shall do such acts and execute such instruments as are reasonably necessary or appropriate for such purpose. The
Licensee shall use the following notices or such similar language as may be approved in advance in writing by Dow Jones when referring to any of the Licensed Indexes or any of the Dow Jones Marks in any Informational Materials:

  

	 	6.1.1	Informational Materials that discuss one or more Products or Licensed Indexes in detail: 

 “Dow Jones,” and ‘[INSERT Name of Index(es)],” are trademarks of Dow Jones & Company, Inc. used under license. The futures and futures options contracts based on these indexes are
not sponsored, endorsed, sold, or promoted by Dow Jones, and Dow Jones makes no representation regarding the advisability of trading in such contracts. 
  

	 	6.1.2	Licensee may use “The Dow” in Informational Materials only in close proximity to the name “Dow Jones”, or the name of a Licensed Index that conspicuously
and prominently uses the name “Dow Jones.” In telecasts where screen space limitations make this impractical, the numerical value of a Licensed Index may be used instead of the name “Dow Jones”, provided it is clear that the
broadcast is referring to a Dow Jones index. 

  

	6.2	 The Licensee agrees that the Dow Jones Marks and all Intellectual Property and other rights, registrations and entitlement thereto, together with all applications,
registrations and filings with respect to any of the Dow Jones Marks and any renewals and extensions of any such applications, registration and filings, are and shall remain the sole and exclusive property of Dow Jones. The Licensee agrees to
cooperate with Dow Jones in the maintenance of such rights and registrations and shall do such acts and execute such instruments as are reasonably necessary or appropriate for such purpose. The Licensee acknowledges that each of the Dow Jones Marks
is part of the business and goodwill of Dow Jones and agrees that it shall not, during the term of this Agreement or thereafter, contest the fact that the Licensee’s rights in the Dow Jones Marks under this Agreement (i) are limited solely
to the use of the Dow Jones Marks in connection with the listing for trading, marketing, and/or promotion of the Products and disclosure about the Products under applicable 

  

 12 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
law as provided in Article II, Sections 1.1—1.3, and (ii) shall cease upon termination of this Agreement, except as otherwise expressly provided
herein. The Licensee recognizes the great value of the reputation and goodwill associated with the Dow Jones Marks and acknowledges that such goodwill associated with the Dow Jones Marks belongs exclusively to Dow Jones, and that Dow Jones is the
owner of all right, title and interest in and to the Dow Jones Marks in connection with the Products. The Licensee further acknowledges that all rights in any translations, derivatives or modifications in the Dow Jones Marks which may be created by
or for the Licensee shall be and shall remain the exclusive property of Dow Jones and said property shall be and shall remain a part of the Intellectual Property subject to the provisions and conditions of this Agreement. During the Term of this
Agreement, Licensee shall not, either directly or indirectly, contest Dow Jones’ exclusive ownership of any of the Intellectual Property. 

  

	 	6.2.1	Dow Jones consents to Licensee’s use of the Dow Jones Mark in conjunction with the Licensee’s own trademark(s). Such resulting mark shall be owned by Dow Jones, and shall
be part of the Intellectual Property of Dow Jones and included in the Dow Jones Marks as defined herein. With respect to any such composite mark: (i) Dow Jones shall not register or apply for registration of such mark; (ii) Dow Jones shall
not use such mark without Licensee’s prior written consent, which shall not be unreasonably withheld; and (iii) after termination or expiration of this Agreement, Dow Jones shall disclaim ownership rights in Licensee’s own trademark
forming a part of such mark and shall assign to Licensee any rights in Licensee’s own trademark forming a part of such mark and the goodwill associated therewith that Dow Jones might have acquired during the Term. 

  

	6.3	In the event that the Licensee learns of any infringement or imitation of any of the Licensed Indexes and/or any Dow Jones Mark, or of any use by any person of a trademark similar
to any of the Dow Jones Marks, it shall promptly notify Dow Jones. Dow Jones shall take such action as it deems advisable for the protection of rights in and to the Licensed Indexes and the Dow Jones Marks and, if requested to do so by Dow Jones,
the Licensee shall cooperate with Dow Jones in all respects, at Dow Jones’ expense, including, without limitation, by being a plaintiff or co-plaintiff and, upon Dow Jones’ reasonable request, by causing its officers to execute appropriate
pleadings and other necessary documents. In no event, however, shall Dow Jones be required to take any action it deems inadvisable. The Licensee shall have no right to take any action which would materially affect any of the Licensed Indexes and/or
any of the Dow Jones Marks without Dow Jones’ prior written approval. 

  

	6.4	 The Licensee shall use its best efforts to protect the goodwill and reputation of Dow Jones, the Licensed Indexes and the Dow Jones Marks in connection with its use
of the Licensed Indexes and any of the Dow Jones Marks under this Agreement. The Licensee shall submit to Dow Jones, for Dow Jones’ review and approval, and the Licensee shall not use until receiving Dow Jones’ approval 

  

 13 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
thereof in writing, all Informational Materials. Dow Jones’ approval shall be required with respect to the use of and description of Dow Jones, any of
the Licensed Indexes or any of the Dow Jones Marks. Dow Jones shall notify the Licensee of its approval or disapproval of any Informational Materials within 72 hours (excluding any day which is a Saturday or Sunday or a day on which the New York
Stock Exchange is closed) following receipt thereof from the Licensee. Once Informational Materials have been approved by Dow Jones, subsequent Informational Materials which do not alter the use or description of Dow Jones, such Licensed Indexes or
such Dow Jones Marks, as the case may be, need not be submitted for review and approval by Dow Jones. 

  

	6.5	Except as may be expressly otherwise agreed in writing by Dow Jones, or as otherwise permitted or required under this Agreement, the Dow Jones Marks and the Licensee’s marks,
the marks of any of their respective affiliates or the marks of any third party, to the extent they appear in any Informational Material, shall appear separately and shall be clearly identified with regard to ownership. Whenever the Dow Jones Marks
are used in any Informational Material in connection with any of the Products, the name of the Licensee shall appear in close proximity to the Dow Jones Marks so that the identity of the Licensee, and its status as an authorized licensee of such Dow
Jones Marks, is clear and obvious. 

  

	6.6	The Licensee agrees that any proposed change in the use of the Dow Jones Marks shall be submitted to Dow Jones for, and shall be subject to, Dow Jones’ prior written consent.

  

	6.7	If at any time Dow Jones is of the opinion that the Licensee is not properly using the Intellectual Property in connection with the Products or Informational Materials, or that the
standard of quality of any of the Products or Informational Materials does not conform to the standards as set forth herein, Dow Jones shall give notice to the Licensee to that effect. Upon receipt of such notice, the Licensee shall forthwith
correct the defects in the non-conforming Products or Informational Materials so that they comply with all required standards or cease (subject to regulatory requirements) the listing, marketing and promotion of the non-conforming Products or
Informational Materials. 

  

	6.8	 If Dow Jones is notified by Licensee of any Unlicensed User trading in Products in the United States *****, Dow Jones shall use its commercially reasonable efforts
to terminate such use, which may include, without limitation, initiating litigation against any such Unlicensed User; provided, however, if Dow Jones does not use or initiate such commercially reasonable efforts within ninety (90) days of such
notice, then Licensee shall have the right to retain the license rights hereunder and notwithstanding Article 3 and Schedule C of this Agreement, the License Fees on a going forward basis shall be a one time fee of $***** until the earlier of
(a) the later of (i) the effective date of a change in the law (a “Change in the Law”) that enables an index publisher, such as Dow Jones, to require a license, such as the one granted under this Agreement, to list and trade
futures contracts and/or options on futures contracts based on an index; and (ii) the 

  

 14 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
cessation of all unauthorized use of the Exclusively Licensed Indexes by Unlicensed Users; and (b) the expiration of the then current term (the
“Suspension Period”); provided, however, except for the license set forth in this Section 6.8, neither party shall have any obligations to the other during such Suspension Period. 

  

	6.9	If any court of competent jurisdiction in the United States issues a final determination that is not appealed within 90 days such that a derivatives exchange, such as Licensee, is
not required to obtain a license, such as the license granted under this Agreement, from an index compiler, such as Dow Jones, in order to list and trade futures contracts and options on futures contracts based on such index, such as the Licensed
Indexes, notwithstanding Article 3 and Schedule C of this Agreement, the License Fees on a going forward basis shall be a one time fee of $***** until the earlier of (a) the effective date of a Change in the Law; and (b) the expiration of
the then current term (also, the “Suspension Period”); provided, however, except for the license granted in this Section 6.9, neither party shall have any obligations to the other during the Suspension Period.

  

	6.10	Except as otherwise expressly provided in Article II, Section 4.7, nothing set forth in this Agreement shall be interpreted as granting Licensee any right to calculate the
values of any of the Licensed Indexes or any other Dow Jones index during or after this Agreement is terminated. 

  

	7.	Proprietary Rights. 

  

	7.1	The Licensee expressly acknowledges and agrees that the Licensed Indexes are selected, compiled, coordinated, arranged and prepared by Dow Jones through the application of methods
and standards of judgment used and developed through the expenditure of considerable work, time and money by Dow Jones. The Licensee also expressly acknowledges and agrees that the Licensed Indexes and the Dow Jones Marks are valuable assets of Dow
Jones and the Licensee agrees that it will take reasonable measures to prevent any unauthorized use of the information provided to it concerning the selection, compilation, coordination, arrangement and preparation of the Licensed Indexes.

  

	7.2	Dow Jones expressly acknowledges and agrees that: (i) Licensee has the exclusive property rights in and to Market Data; (ii) Market Data constitutes valuable information
and proprietary rights of Licensee; and (iii) Licensee’s trademarks and trade names, including but not limited to, Chicago Board of Trade, Board of Trade, and CBOT, are valuable assets of Licensee. 

  

	7.3	Each party shall treat as confidential and shall not disclose or transmit to any third party any Confidential Information. 

  

	7.4	 Notwithstanding the foregoing, either party may reveal Confidential Information to any regulatory agency or court of competent jurisdiction if such information to
be 

  

 15 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
disclosed is (i) approved in writing by the providing party for disclosure or (ii) required by law, regulatory agency or court order to be
disclosed by the receiving party, provided, if permitted by law, that prior written notice of such required disclosure is given to the providing party and provided further that the receiving party shall cooperate with the providing party to limit
the extent of such disclosure. The provisions of Article II, Sections 7.3 and 7.4 shall survive termination or expiration of this Agreement for a period of five (5) years from disclosure by either party to the other of the last item of such
Confidential Information. 

  

	8.	Warranties: Disclaimers. 

  

	8.1	Each party represents and warrants to the other that it has the authority to enter into this Agreement according to its terms, and that its execution and delivery of this Agreement
and its performance hereunder will not violate any agreement applicable to it or violate any applicable laws, rules or regulations. Dow Jones represents that it owns and has the right to license hereunder the Intellectual Property licensed
hereunder. The Licensee represents and warrants to Dow Jones that the Products listed for trading, and the marketing and promotion thereof, by the Licensee will not violate any agreement applicable to the Licensee or violate any applicable laws,
rules or regulations, including without limitation, securities, commodities, and banking laws. 

  

	8.2	The Licensee shall include the statement contained in Schedule D hereto in each contract designation application and in the terms and conditions of any Products (and upon request
shall furnish copies thereof to Dow Jones), and the Licensee expressly agrees to be bound by the terms of the statement contained in Schedule D hereto (which terms are expressly incorporated herein by reference and made a part hereof). Any changes
in the statement contained in Schedule D hereto must be approved in advance in writing by an authorized officer of Dow Jones. 

  

	8.3	Without limiting the disclaimers set forth in this Agreement (including in Schedule D hereto), in no event shall the cumulative liability of Dow Jones to the Licensee and its
respective affiliates under or relating to this Agreement at any time exceed the aggregate amount of License Fees received by Dow Jones pursuant to this Agreement prior to such time. 

  

	8.4	 Notwithstanding any other provision of this Agreement, in no event shall Dow Jones be liable to the Licensee and its affiliates for damages of any kind (whether
monetary, special, indirect, exemplary, incidental, consequential or otherwise) in connection with any breach by Dow Jones of any of its covenants under this Agreement. In addition, in no event shall either Dow Jones, on the one hand, or the
Licensee on the other hand, be liable to the one another and their respective affiliates for more than an aggregate of $***** (in respect of any and all claims) for any special, indirect, exemplary, incidental or consequential damages (including
loss of profits or savings, even if such other party has been advised, 

  

 16 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
knows or should know of the possibility of same arising in connection with this Agreement; provided, however, the foregoing limitation of liability shall not
apply to (a) any claims of Dow Jones in respect of the fees payable pursuant to Article II, Section 3 hereunder or (b) the parties’ obligations pursuant to Article II, Section 9. 

  

	9.	Indemnification. 

  

	9.1	The Licensee shall indemnify and hold harmless Dow Jones and its affiliates, and their respective officers, directors, members, employees and agents, against any and all judgments,
damages, liabilities, costs and losses of any kind (including reasonable attorneys’ and experts’ fees) (collectively, “Losses”) that arise out of or relate to (i) any breach by the Licensee of its representations and
warranties or covenants under this Agreement, or (ii) any claim, action or proceeding that arises out of or relates to (x) this Agreement or (y) the Products (including, without limitation, spread trading, special quoting and pricing
mechanisms); provided, however, that Dow Jones must promptly notify the Licensee in writing of any such claim, action or proceeding (but the failure to do so shall not relieve the Licensee of any liability hereunder except to the
extent the Licensee has been materially prejudiced there from). The Licensee may elect, by written notice to Dow Jones within ten (10) days after receiving notice of such claim, action or proceeding from Dow Jones, to assume the defense thereof
with counsel reasonably acceptable to Dow Jones. If the Licensee does not so elect to assume such defense or disputes its indemnity obligation with respect to such claim, action or proceeding, or if Dow Jones reasonably believes that there are
conflicts of interest between Dow Jones and the Licensee or that additional defenses are available to Dow Jones with respect to such defense, then Dow Jones shall retain its own counsel to defend such claim, action or proceeding, at the
Licensee’s expense. The Licensee shall periodically reimburse Dow Jones for its expenses incurred under this Section 9. Dow Jones shall have the right, at its own expense, to participate in the defense of any claim, action or proceeding
against which it is indemnified hereunder; provided, however, that Dow Jones shall have no right to control the defense, consent to judgment, or agree to settle any such claim, action or proceeding without the written consent of the
Licensee unless Dow Jones waives its right to indemnity hereunder. The Licensee, in the defense of any such claim, action or proceeding, except with the written consent of Dow Jones, shall not consent to entry of any judgment or enter into any
settlement which (i) does not include, as an unconditional term, the grant by the claimant to Dow Jones of a release of all liabilities in respect of such claims or (ii) otherwise adversely affects the rights of Dow Jones.

  

	9.2	 Notwithstanding Section 9.1, the Licensee shall not have any obligation to indemnify and hold harmless Dow Jones and its affiliates, and their respective
officers, directors, members, employees and agents, to the extent that Losses arise out of or relate to (i) a breach by Dow Jones of its representations, warranties or covenants under this Agreement, (ii) the willful or reckless misconduct
of any of Dow Jones’ officers, directors, employees or agents acting within the scope of their authority, or (iii) miscalculations or errors in an Index 

  

 17 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
originated by Dow Jones (i.e., not including miscalculations or errors resulting from wrong information received by Dow Jones or from Dow Jones’ lack of
information). 

  

	9.3	The indemnification provisions set forth herein are solely for the benefit of Dow Jones and are not intended to, and do not, create any rights or causes of actions on behalf of any
third party. 

  

	10.	Suspension of Performance. 

 Notwithstanding anything herein to the
contrary, neither Dow Jones nor the Licensee shall bear responsibility or liability to each other or to third parties for any Losses arising out of any delay in or interruptions of performance of their respective obligations under this Agreement due
to any act of God, act of governmental authority, or act of public enemy, or due to war, the outbreak or escalation of hostilities, riot, fire, flood, civil commotion, insurrection, labor difficulty (including, without limitation, any strike, other
work stoppage, or slow-down), severe or adverse weather conditions, power failure, communications line or other technological failure, or other similar cause beyond the reasonable control of the party so affected; provided, however,
that nothing in this Section 10 shall affect the Licensee’s obligations under Article II, Section 9. 
  

	11.	Injunctive Relief. 

 In the event of a material breach by a
Breaching Party of provisions of this Agreement relating to the Confidential Information or Intellectual Property of the Non-breaching Party, the Breaching Party acknowledges and agrees that damages would be an inadequate remedy and that the
Non-breaching Party shall be entitled to preliminary and permanent injunctive relief to preserve such confidentiality or limit improper disclosure of such Confidential Information or Intellectual Property, but nothing herein shall preclude the
Non-breaching Party from pursuing any other action or remedy for any breach or threatened breach of this Agreement. All remedies under this Article II, Section 11 shall be cumulative. 
  

	12.	Other Matters. 

  

	12.1	 This Agreement is solely and exclusively between the parties hereto and, except to the extent otherwise expressly provided herein, shall not be assigned or
transferred, nor shall any duty hereunder be delegated, by either party, without the prior written consent of the other party, and any attempt to so assign or transfer this Agreement or delegate any duty hereunder without such written consent shall
be null and void; provided, however, that any affiliate which, directly or indirectly, Controls, is Controlled by or is under common Control with the Licensee may use the Licensed Indexes and the Dow Jones Marks in connection with the
issuance, marketing and promotion of the Products, provided that such affiliate shall enter into a Sublicense Agreement with Dow Jones and Licensee and such affiliate shall be jointly and severally liable to Dow Jones hereunder; 

  

 18 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	 	 
and, provided, further, that Licensee may assign this Agreement in its entirety to an affiliate which it directly or indirectly Controls, is
Controlled by or is under common Control; and provided, further, that Dow Jones may assign this Agreement in its entirety, without the consent of Licensee, in connection with a sale of all or substantially all the assets of Dow Jones
Indexes or otherwise to a successor-in-interest to the Dow Jones Indexes’ business unit. This Agreement shall be valid and binding on the parties hereto and their successors and permitted assigns. 

  

	12.2	This Agreement, including the Schedules hereto (which are hereby expressly incorporated into and made a part of this Agreement), constitutes the entire agreement of the parties
hereto with respect to its subject matter, and supersedes any and all previous agreements between the parties with respect to the subject matter of this Agreement. There are no oral or written collateral representations, agreements or understandings
except as provided herein. 

  

	12.3	No waiver, modification or amendment of any of the terms and conditions hereof shall be valid or binding unless set forth in a written instrument signed by duly authorized officers
of both parties. The delay or failure by any party to insist, in any one or more instances, upon strict performance of any of the terms or conditions of this Agreement or to exercise any right or privilege herein conferred shall not be construed as
a waiver of any such term, condition, right or privilege, but the same shall continue in full force and effect. 

  

	12.4	No breach, default or threatened breach of this Agreement by either party shall relieve the other party of its obligations or liabilities under this Agreement with respect to the
protection of the property or proprietary nature of any property which is the subject of this Agreement. 

  

	12.5	All notices and other communications under this Agreement shall be (i) in writing, (ii) delivered by hand (with receipt confirmed in writing), by registered or certified
mail (return receipt requested), or by facsimile transmission (with receipt confirmed in writing), to the address or facsimile number set forth below or to such other address or facsimile number as either party shall specify by a written notice to
the other, and (iii) deemed given upon receipt. 

  

			
	 If to Dow Jones:
	 	Dow Jones & Company, Inc.
		 	4300 N. Route 1
		 	South Brunswick, New Jersey 08852
		 	Attn: President/Dow Jones Indexes
		 	Fax No.: 609 520
		
	With a copy to:	 	Dow Jones & Company, Inc.
		 	4300 N. Route 1
		 	South Brunswick, NJ 08852
		 	Attn: Legal Department
		 	Fax: 609 520 4021

  

 19 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

			
	If to the Licensee:	 	Board of Trade of the City of Chicago, Inc.
		 	141 West Jackson Boulevard
		 	Chicago, Illinois 60604
		 	Attn: General Counsel
		 	Fax No. (312) 341-3392
		
	With a copy to:	 	Chicago Mercantile Exchange Inc.
		 	20 S. Wacker Drive
		 	Chicago, Illinois 60606
		 	Attn: General Counsel
		 	Fax No. (312) 930-3323

  

	12.6	This Agreement shall be interpreted, construed and enforced in accordance with the laws of the State of New York without reference to or inclusion of the principles of choice of law
or conflicts of law of that jurisdiction. It is the intent of the parties that the substantive law of the State of New York govern this Agreement and not the law of any other jurisdiction incorporated through choice of law or conflicts of law
principles. Each party agrees that any legal action, proceeding, controversy or claim between the parties arising out of or relating to this Agreement may be brought and prosecuted only in the United States District Court for the Southern District
of New York or in the Supreme Court of the State of New York in and for the First Judicial Department, and by execution of this Agreement each party hereto submits to the exclusive jurisdiction of such court and waives any objection it might have
based upon improper venue or inconvenient forum. Each party hereby waives any right it may have to a jury trial in connection with any legal action, proceeding, controversy or claim between the parties arising out of or relating to this Agreement.

  

	12.7	This Agreement (and any related agreement or arrangement between the parties hereto) is solely and exclusively for the benefit of the parties hereto and their respective successors,
and nothing in this Agreement (or any related agreement or arrangement between the parties hereto), express or implied, is intended to or shall confer on any other person or entity (including, without limitation, any purchaser of any Products issued
by the Licensee), any rights, benefits or remedies of any nature whatsoever under or by reason of this Agreement (or any such related agreement or arrangement between the parties hereto). 

  

	12.8	Article II, Section 4, Sections 7.3 and 7.4 (as provided therein), Sections 8.3 and 8.4, 9, 11 and 12 shall survive the expiration or termination of this Agreement.

  

 20 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  

	12.9	The parties hereto are independent contractors. Nothing herein shall be construed to place the parties in the relationship of partners or joint venturers, and neither party shall
acquire any power, other than as specifically and expressly provided in this Agreement, to bind the other in any manner whatsoever with respect to third parties. 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first set forth above. 
  

							
	 BOARD OF TRADE OF THE CITY OF CHICAGO, INC.
	 	DOW JONES & COMPANY, INC.
				
	By:	 	 /s/ Craig S. Donohue
	 	By:	 	 /s/ Michael A. Petronella

	Name:	 	Craig S. Donohue	 	Name:	 	Michael A. Petronella
	Title:	 	Chief Executive Officer	 	Title:	 	President, Dow Jones Indexes

  

 21 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 INDEX OF ATTACHMENTS 
 SCHEDULES:

  

			
	Schedule A	  	Licensed Indexes
	Schedule B	  	Licensed Marks
	Schedule C	  	License Fees
	Schedule D	  	Disclaimer
	Schedule E	  	Draft Sublicense

  

 22 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 SCHEDULE A. LICENSED INDEXES 
 1. The following Licensed Indexes are “Exclusively Licensed Indexes”: 
  

	 	1.1	Dow Jones Composite Index 

  

	 	1.2	Dow Jones Industrial Average Index 

  

	 	1.3	Dow Jones Transportation Average Index 

  

	 	1.4	Dow Jones Utility Average Index 

 2. The following Licensed Indexes are
“Non-exclusively Licensed Indexes”: 
  

	 	2.1	Dow Jones Global Indexes listed below 

  

	 	2.2	Dow Jones U.S. Real Estate Index 

 3. The Dow Jones Global Indexes
include: 
  

			
	 Licensed Index:
	 	Target Launch Date:

 None as of the Effective Date. 
  

 23 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 SCHEDULE B. DOW JONES MARKS 
 “Dow Jones Marks” shall mean the following trademarks: 
  

	 	1.	DJGI 

	 	2.	DJIA 

	 	3.	The Dow 

	 	4.	Dow Jones 

	 	5.	Dow Jones Composite Index 

	 	6.	Dow Jones Global Indexes 

	 	7.	Dow Jones Industrial Average 

	 	8.	Dow Jones Transportation Average 

	 	9.	Dow Jones U.S. Real Estate Index 

	 	10.	Dow Jones Utility Average 

  

 24 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 SCHEDULE C. LICENSE FEES 
 Licensee shall pay License Fees in accordance with the following: 
 1. Exclusively Licensed Indexes 
 For each Product traded based on an Exclusively Licensed Index, (the “Exclusive Products”) Licensee will pay to Dow Jones, or a Dow Jones affiliate designated
by Dow Jones, a License Fee as follows: 
  

	 	(i)	$***** per contract traded (round turn) until the cumulative amount of all License Fees for all contracts with respect to the Exclusive Products in a calendar year equals $*****;
and 

  

	 	(ii)	$***** per contract traded (round turn) for such contracts traded after the cumulative amount of all License Fees for all contracts with respect to the Exclusive Products in a
calendar year equals $*****. 

 The fees described in this Schedule C, Sections 1 and 2 shall be the “Per-Contract Fees”. 

2. Non-exclusively Licensed Indexes 
 For each Product traded based
on an Non-exclusively Licensed Index, Licensee will pay to Dow Jones, or a Dow Jones affiliate designated by Dow Jones, a License Fee of $***** per contract (round turn). 
 3. Annual Minimum Fees 
 The total license fees Licensee shall pay to Dow Jones during the Initial Term of the
Agreement shall be at least the amounts listed below. Licensee shall pay to Dow Jones the annual minimum payments set forth below payable quarterly in arrears (each, a “Quarterly Minimum”). 
  

				
	 Year
	  	Minimum License Fee
	 2008
	  	$	*****
	 2009
	  	$	*****
	 2010
	  	$	*****
	 2011
	  	$	*****
	 2012
	  	$	*****
	 2013
	  	$	*****
	 2014
	  	$	*****

 During the first Renewal Term, the Per-Contract Fees set forth in sections 1 and 2 of this Schedule C shall remain
the same, and during each year of the first Renewal Term, the annual minimum License Fees described in section 3 of this Schedule C shall not exceed $*****. 
  

 25 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 4. Payments 
 The License Fees payable
pursuant to this Schedule C shall be determined at the end of each calendar quarter. At such time during any calendar year that the cumulative Per Contract Fees exceed the Quarterly Minimum payment(s) paid thus far in respect of such year, the
Licensee will pay Dow Jones (or the Dow Jones affiliate designated by Dow Jones) the excess amount within thirty (30) days after the end of each calendar quarter. Each payment shall be accompanied by a full accounting of the basis for the
calculation of the License Fees. 
 If during any calendar year, the Quarterly Minimum exceeds the actual Per-Contract Fees payable for one or more quarters,
then Licensee shall adjust the final quarterly payment for such calendar year to compensate for any over payment in any previous quarter(s). For example, if in 2008 the actual Per-Contract Fees payable for the four quarters were $*****, $*****,
$***** and $***** then the quarterly payments would be $***** (the Quarterly Minimum), $***** (the Quarterly Minimum), $***** and $***** ($***** less $*****). 
 In the event of termination pursuant to the provisions of this Agreement, Licensee shall pay Dow Jones pro rata Quarterly Minimum payment and Per-Contract Fees through the effective termination date. 
 5. Confidentiality 
 The terms hereof shall be deemed
“Confidential Information” for purposes of this Agreement. 
  

 26 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 SCHEDULE D. DISCLAIMER 
 The [Products] are not sponsored, endorsed, sold or promoted by Dow Jones. Dow Jones makes no representation or warranty, express or implied, to the owners of the [Product(s)] or any member of the public regarding the
advisability of trading in the Product(s). Dow Jones’ only relationship to the Licensee is the licensing of certain trademarks and trade names of Dow Jones and of the [INSERT Name of Index(es)J which is determined, composed and calculated by
Dow Jones without regard to [the Licensee] or the [Product(s)1, Dow Jones has no obligation to take the needs of [the Licensee] or the owners of the [Product(s)] into consideration in determining, composing or calculating [INSERT Name of Index(es)].
Dow Jones is not responsible for and has not participated in the determination of the timing of, prices at, or quantities of the [Product(s)] to be listed or in the determination or calculation of the equation by which the [Product(s)] are to be
converted into cash. Dow Jones has no obligation or liability in connection with the administration, marketing or trading of the [Product(s)]. 
 DOW JONES DOES NOT GUARANTEE THE ACCURACY AND/OR THE COMPLETENESS OF THE [INSERT NAME OF INDEX(ES)] OR ANY DATA INCLUDED THEREIN AND DOW JONES SHALL HAVE NO LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. DOW JONES MAKES NO
WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY [THE LICENSEE], OWNERS OF THE [PRODUCT(S)], OR ANY OTHER PERSON OR ENTITY FROM THE USE OF THE [INSERT NAME OF INDEX(ES)] OR ANY DATA INCLUDED THEREIN. DOW JONES MAKES NO EXPRESS OR
IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES, OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE [INSERT NAMES OF INDEX(ES)] OR ANY DATA INCLUDED THEREIN, WITHOUT LIMITING ANY OF THE FOREGOING, IN NO
EVENT SHALL DOW JONES HAVE ANY LIABILITY FOR ANY LOST PROFITS OR INDIRECT, PUNITIVE, SPECIAL OR CONSEQUENTIAL DAMAGES (INCLUDING LOST PROFITS), EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES. THERE ARE NO THIRD PARTY BENEFICIARIES OF ANY
AGREEMENTS OR ARRANGEMENTS BETWEEN DOW JONES AND [THE LICENSEE]. 
  

 27 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 SCHEDULE E. SUBLICENSE 
 This Sublicense Agreement (the “Sublicense Agreement”), dated as of                     , is made by
and among
                                        
                     (the “Sublicensee”), Dow Jones & Company, Inc. (“Licensor”), and Chicago Board of Trade, Inc.
(“Licensee” or “Sublicensor”). 
 WITNESSETH : 
 WHEREAS, pursuant to that certain License Agreement, dated as of
                    , by and between Licensor and Licensee (“License Agreement”), Licensor has granted Licensee a license to use
certain copyright, trademark and proprietary rights and trade secrets of Licensor (as further described in the License Agreement, the “Intellectual Property”) in connection with the issuance, sale, marketing and/or promotion of certain
financial products (as further defined in the License Agreement, the “Products”); 
 WHEREAS, Sublicensee wishes to issue, sell,
market and/or promote the Products and to use and refer to the Intellectual Property in connection therewith; and 
 WHEREAS, all capitalized
terms used herein shall have the meanings assigned to them in the License Agreement unless otherwise defined herein. 
 NOW, THEREFORE, in
consideration of the premises and the mutual covenants and agreements contained herein, the parties hereto agree as follows: 
 1.
License. Sublicensor hereby grants to Sublicensee a non-exclusive and non-transferable sublicense to use the Intellectual Property in connection with the issuance, distribution, marketing and/or promotion of the Products (as modified by
Appendix A hereto, if applicable). 
 2. The Sublicensee acknowledges that it has received and read a copy of the License Agreement
(excluding Section 3 and Schedule C) and agrees to be bound by all the provisions thereof, including, without limitation, those provisions imposing any obligations on the Licensee (including, without limitation, the indemnification obligations
in Section 9 insofar as such obligations arise out of or relate to the Products to be sold, issued, marketed and/or promoted by the Sublicensee). 
 3. Sublicensee agrees that its obligations under the License Agreement pursuant to Section 2 of this Sublicense Agreement are as principal and shall be unaffected by any defense or claim that Licensee may have
against Licensor. 
 4. This Sublicense Agreement shall be construed in accordance with the laws of the State of New York without reference
to or inclusion of the principles of 

  

 28 

 Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and
Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission. 
  
 
choice of law or conflicts of law of that jurisdiction. It is the intent of the parties that the substantive law of the State of New York govern this
Agreement and not the law of any other jurisdiction incorporated through choice of law or conflicts of law principles. Each party agrees that any legal action, proceeding, controversy or claim between the parties arising out of or relating to this
Agreement may be brought and prosecuted only in the United States District Court for the Southern District of New York or in the Supreme Court of the State of New York in and for the First Judicial Department, and by execution of this Agreement each
party hereto submits to the exclusive jurisdiction of such court and waives any objection it might have based upon improper venue or inconvenient forum. Each party hereto hereby waives any right it may have in the future to a jury trial in
connection with any legal action, proceeding controversy or claim between the parties arising out of or relating to this Agreement. 
 IN
WITNESS WHEREOF, the parties hereto have executed this Sublicense Agreement as of the date first set forth above. 
  

			
	SUBLICENSEE
		
	By:	 	  

	Title:	 	  

	
	LICENSEE
		
	By:	 	  

	Title:	 	  

	
	DOW JONES & COMPANY, INC.
	
	  

	By:	 	Michael A. Petronella
	Title:	 	President, Dow Jones Indexes

  

 29Amended and Restated CME Group Inc. Severance Plan

 Exhibit 10.9 
 CME Group Inc. 
 SEVERANCE PLAN 
 for Corporate Officers 

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	I.	  	Purpose, Intent, and Effective Date	  	1
	II.	  	Definitions	  	1
		  	2.1 “Administrator”	  	1
		  	2.2 “Cause”	  	1
		  	2.3 “Continuation Coverage”	  	1
		  	2.4 “Corporate Officer”	  	1
		  	2.5 “Employee”	  	1
		  	2.6 “Employer”	  	2
		  	2.7 “Involuntary Termination”	  	2
		  	2.8 “Merger”	  	2
		  	2.9 “Qualifying Merger Termination”	  	2
		  	2.10 “Qualifying Standard Termination”	  	2
		  	2.11 “Qualifying Termination”	  	2
		  	2.12 “Severance Benefit”	  	2
		  	2.13 “Severance Pay”	  	2
		  	2.14 “Severance Period”	  	2
		  	2.15 “Severance Schedule”	  	2
		  	2.16 “Supplemental Serverance Benefits”	  	2
		  	2.17 “Termination of Employment”	  	3
	III.	  	Eligibility for Benefits.	  	3
		  	3.1 Severance Benefits	  	3
		  	3.2 Supplemental Severance Benefits	  	3
		  	3.3 Ineligible Employees	  	3
	IV.	  	General Provisions	  	3
		  	4.1 Timing of Severance Pay	  	3
		  	4.2 Withholding	  	3
		  	4.3 Amendment and Termination	  	3
		  	4.4 Payments Conditioned on Release	  	.4
		  	4.5 Return of Property	  	4
		  	4.6 Breach of Obligations to Employer.	  	4
		  	4.7 Offsets	  	4
		  	4.8 Governing Law	  	4
		  	4.9 Nonassignability	  	5
		  	4.10 Severance Pay Not Compensation	  	.5
		  	4.11 Right of Offset	  	5
		  	4.12 Severability	  	5
		  	4.13 Recovery of Payments Made by Mistake	  	5
		  	4.14 Representations Contrary to Plan	  	5
		  	4.15 Plan Funding	  	5
		  	4.16 Written Agreement	  	5
		  	4.17 No Right to Other Claims.	  	5
		  	4.18 Code Section 409A	  	5
	V.	  	Plan Administration.	  	6
		  	5.1 Operation and Administration of Plan by Administrator	  	6
		  	5.2 Reliance on Documents, Instruments, Etc	  	6
		  	5.3 Administrative Expenses	  	6
		  	5.4 Bond, Compensation, Indemnification of Administrator	  	6
		  	5.5 More Than One Fiduciary Capacity.	  	6
		  	5.6 Filing of Claims; Denial of Claims; Appeals	  	7
		
	Appendix A	  	A-1
		
	Appendix B	  	B-1

  

 i 

 CME Group Inc. Severance Plan for Corporate Officers 
  

	I.	Purpose, Intent, and Effective Date. 

 CME
Group Inc. (the “Company”) hereby adopts this CME Group Inc. Severance Plan for Corporate Officers (the “Plan”) as a component of the Chicago Mercantile Exchange Inc. Employee Benefit Plan. The provisions of this Plan supersede
any prior Employer severance benefit plan documents, policies, and programs (regardless of whether such policies and programs were written). The Board of Directors of the Company, or its designee, may designate one or more officers (by office or by
name) to perform any act specified to be done by “the Company” under this Plan. 
 The purpose of the Plan is to provide severance
benefits to certain employees of the Employer in the event that their employment is terminated in specified circumstances. 
 The Plan is
intended to constitute an unfunded welfare benefit plan for purposes of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). 
  

	II.	Definitions. 

  

	 	2.1	“Administrator” means the person(s) or committee designated by the Company to administer the Plan. The Administrator shall be the “administrator” and the
“named fiduciary” of the Plan for purposes of ERISA. Unless there is another designation by the Company, the Administrator is the Compensation Committee of the Board of Directors of the Company. 

  

	 	2.2	“Cause” means engaging in conduct that violates any of the Employer’s policies and/or is harmful to the Employer. Whether a Termination of Employment is for
Cause will be determined in each case by the Administrator in its sole discretion. 

  

	 	2.3	“Continuation Coverage” means (i) the continuation of health plan coverage under Part 6 of Title I of ERISA (“COBRA”) and (ii) the COBRA-like
continuation of health plan coverage of an Employee’s domestic partner under the terms of the Employer’s group health plan. 

  

	 	2.4	“Corporate Officer” means any employee of the Employer at the Management Team, Managing Director, or Director level. 

  

	 	2.5	“Employee” means a Corporate Officer of the Employer who provides personal services to the Employer for compensation, exclusive of individuals who are
(a) covered by (i) an individual contract of employment that provides severance benefits, (ii) an individual severance agreement, unless such contract or agreement is evidenced in writing and makes reference to the terms of this Plan,
or (iii) any other severance plan of the Employer or an affiliate of the Employer; (b) classified as independent contractors by the Company for employment tax purposes (whether or not such classification is challenged or upheld); or
(c) not on the Employer’s United States payroll. The Administrator shall have the authority to determine, in its sole and complete discretion and on a case-be-case basis, whether an individual constitutes an Employee for purposes of the
Plan. 

  

 1 

	 	2.6	“Employer” means Chicago Mercantile Exchange Inc., GFX Corporation, and any other employer that is a member of controlled group of corporations or a group of trades
or businesses under common control, as determined under Sections 210(c) and 210(d) of ERISA, of which the Company is also a member, and that is designated by the Company as eligible to participate in the Plan. 

  

	 	2.7	“Involuntary Termination” means an involuntary Termination of Employment by the Employer other than by reason of death or disability. In no event will an Employee
be deemed to incur an Involuntary Termination if he or she is offered a transfer to a position within the Employer or a position with an affiliate of the Employer, irrespective of whether the Employee elects to accept such offer.

  

	 	2.8	“Merger” means merger of CBOT Holdings, Inc. into Chicago Mercantile Exchange Holdings Inc. 

  

	 	2.9	“Qualifying Merger Termination” means an Involuntary Termination, other than for Cause, that the Administrator determines in its sole discretion results from the
Merger and that occurs within two (2) years after the Merger. 

  

	 	2.10	“Qualifying Standard Termination” means an Involuntary Termination, other than for Cause and other than a Qualifying Merger Termination, that the Administrator
determines in its sole discretion is due to the elimination of Employee’s job or a reduction in force or due to the unacceptable performance of the Employee’s job duties and responsibilities. 

  

	 	2.11	“Qualifying Termination” means a Qualifying Merger Termination or a Qualifying Standard Termination. 

  

	 	2.12	“Severance Benefit” means any payment or benefit described in the Severance Schedule to this Plan to which an Employee is entitled upon a Qualifying Termination.

  

	 	2.13	“Severance Pay” means the portion of a Severance Benefit consisting of severance pay. 

  

	 	2.14	“Severance Period” means the period described in the applicable Severance Schedule for which an Employee is entitled to receive Severance Pay.

  

	 	2.15	“Severance Schedule” means the applicable schedule attached as an appendix to this Plan, as such schedule may be modified from time to time by the Administrator,
that describes the Severance Benefits and Supplemental Severance Benefits that an Employee may be entitled to receive pursuant to this Plan. 

  

	 	2.16	“Supplemental Severance Benefits” Supplemental Severance Benefits means any discretionary supplemental benefits that are in addition to any Severance Benefits,
including, without limitation, any such discretionary supplemental benefits provided in accordance with the applicable Severance Schedule. 

  

 2 

	 	2.17	“Termination of Employment” means a complete severance of an Employee’s employment relationship with the Employer, as determined by the Administrator in its
sole discretion. 

  

	III.	Eligibility for Benefits. 

  

	 	3.1	Severance Benefits. Subject to the provisions of Article IV, an Employee who experiences a Qualifying Termination during the term of this Plan shall be eligible to receive
Severance Benefits. Such Severance Benefits shall consist of the benefits set forth in Appendix A in the case of a Qualifying Standard Termination and the benefits set forth in Appendix B in the case of a Qualifying Merger Termination.

  

	 	3.2	Supplemental Severance Benefits. The Administrator may award Supplemental Severance Benefits to an Employee who experiences a Qualifying Termination in the
Administrator’s sole discretion and on a case-by-case basis. The determination as to which Supplemental Severance Benefits will be offered, if any, and the amount of such benefit, shall be determined by the Administrator in its sole discretion;
provided, however, that any cash Supplemental Severance Benefit shall in no event cause an Employee’s total cash Severance Benefits and cash Supplemental Severance Benefits to exceed 52 weeks of Base Salary. 

  

	 	3.3	Ineligible Employees. Except as otherwise provided in this Section 3.3, an Employee who experiences a Termination of Employment that is not a Qualifying Termination (a
“Nonqualifying Termination”) shall not be entitled to Severance Benefits or Supplemental Severance Benefits under this Plan. Notwithstanding the foregoing, the Administrator may determine to provide benefits under the Plan upon a
Nonqualifying Termination in individual cases due to special circumstances, the amount and nature of such benefits to be determined by the Administrator in its sole discretion. 

  

	IV.	General Provisions. 

  

	 	4.1	Timing of Severance Pay. Any Severance Pay that is due to an eligible Employee pursuant to Article III shall be paid in a lump sum within 14 days of the later of the date on
which a signed Release and Waiver (as described in Section 4.4) is received by the Employer or has become irrevocable or, in the event the Administrator waives the Release and Waiver requirement, within 14 days of the Employee’s
Termination of Employment. 

  

	 	4.2	Withholding. The Administrator shall withhold from any Severance Benefits and Supplemental Severance Benefits all federal and state income, FICA, and other employment taxes,
and any other amounts required or permitted to be withheld under any agreement with the Employee involved, applicable law or other employee benefit plans of the Employer. 

  

	 	4.3	Amendment and Termination. The Company may amend or terminate this Plan at any time and without prior notice; provided, however, that in no event shall any such amendment or
termination affect, in any manner, the entitlement to Severance Benefits or Supplemental Severance Benefits, if any, of an Employee who, prior to the date of such amendment or termination, was determined to be eligible for such payments.

  

 3 

	 	4.4	Payments Conditioned on Release. Eligibility for the receipt of Severance Benefits or Supplemental Severance Benefits hereunder is expressly conditioned upon the execution by
the Employee of a comprehensive settlement agreement and release and waiver (“Release and Waiver”), in a form to be determined from time to time by the Administrator; provided, however, that the Administrator may, in its sole discretion,
waive this requirement, in whole or in part, with respect to all or a part, with respect to all or a part of an Employee’s benefits under the Plan. Except to the extent the requirement to execute such an agreement is waived by the
Administrator, Employees who do not execute such an agreement on or before the Release and Waiver Deadline, or who revoke such an agreement, will not be eligible for Severance Benefits or Supplemental Severance Benefits, regardless of the reason for
the Termination of Employment. For purposes hereof, the “Release and Waiver Deadline” means the deadline prescribed by the Administrator for the execution of such agreement; provided, however, that such deadline shall in no event be later
than February 28 of the year following the year in which the Termination of Employment occurs. 

  

	 	4.5	Return of Property. All Employer property, including information and reports, data, files, memoranda, records, credit cards, keys, passwords, computers, software,
telecommunications equipment, and other physical or personal property that the eligible Employee received, prepared or helped prepare in connection with the Employee’s employment with the Employer, must be returned by that Employee on or before
the Employee’s last day of employment in order for such Employee to commence receiving severance benefits under the Plan. 

  

	 	4.6	Breach of Obligations to Employer. No otherwise eligible Employee shall be entitled to any Severance Benefits or Supplemental Severance Benefits under the Plan if, in the
sole discretion of the Administrator, such Employee is in breach or violation of any contractual or other legal obligation to the Employer, including, but not limited to, obligations concerning non-disclosure of confidential information and
post-employment restrictions on competition with the Employer. 

  

	 	4.7	Offsets. Any Severance Benefits or Supplemental Severance Benefits payable under the Plan shall be reduced dollar-for-dollar by any severance payments or benefits provided by
the Employer under any other plan or arrangement or pursuant to applicable law, including without limitation any payments required pursuant to the Worker Adjustment and Retraining Notification Act (the “WARN Act”) and/or the Illinois
Worker Adjustment and Retraining Notification Act (“IL WARN Act”). If Termination of Employment is deemed to be covered by the WARN Act and/or the IL WARN Act, any severance benefits that may be payable pursuant to this Plan shall be
considered payment required under the WARN Act and/or the IL WARN Act. 

  

	 	4.8	Governing Law. This Plan, to the extent not preempted by ERISA or any other federal law, shall be governed by and construed in accordance with the laws of the State of
Illinois. 

  

 4 

	 	4.9	Nonassignability. Payments that are made under this Plan may not be assigned by any Employee, except as required by federal or non-preempted state law.

  

	 	4.10	Severance Pay Not Compensation. The period for which Severance Payments may be computed and the payments provided under this Plan shall not constitute employment,
compensation or salary for purposes of determining participation in, or other benefits under, any other benefit plan of the Employer. Severance payments shall also not be considered wages for work performed by the Employee for any purpose under
state or federal law. 

  

	 	4.11	Right of Offset. By accepting Severance Benefits or Supplemental Severance Benefits under the Plan, the Employee agrees that the Administrator, in its sole discretion, may
withhold from any amounts payable under this Plan any amounts that are owed to the Employer by the Employee. 

  

	 	4.12	Severability. Any provision herein that may be unenforceable will be deemed to be severed from the remainder hereof, with such remaining provisions being given full force and
effect. 

  

	 	4.13	Recovery of Payments Made by Mistake. An eligible Employee shall be required to return to the Employer any Plan severance benefit payment, or portion thereof, made by a
mistake of fact or law. 

  

	 	4.14	Representations Contrary to Plan. Except as otherwise provided herein, no employee, officer, or director of the Employer has the authority to alter, vary or modify the terms
of the Plan, except by means of an authorized written amendment to the Plan. No verbal or written representations contrary to the terms of the Plan and its written amendments shall be binding upon the Plan, the Administrator or the Employer.

  

	 	4.15	Plan Funding. No eligible Employee shall acquire by reason of the Plan any right in or title to any assets, funds or property of the Employer. Any Severance Benefits or
Supplemental Severance Benefits that become payable under the Plan are unfunded obligations of the Employer and shall be paid from the general assets of the Employer. No employee, officer, director or agent of the Employer guarantees, in any manner,
the payment of Plan severance benefits. 

  

	 	4.16	Written Agreement. Any severance benefits to which an eligible Employee may be entitled to receive under the Plan shall be communicated to such Employee in writing. An
eligible Employee shall not be entitled to receive any severance benefits under this Plan other than those benefits that are specifically communicated to that Employee in such writing. 

  

	 	4.17	No Right to Other Claims. Neither an eligible Employee, his or her dependents, his or her beneficiaries, nor anyone else has the right or claim to benefits under this Plan,
other than those described in the Plan. 

  

	 	4.18	Code Section 409A. All benefits under this Plan are intended either to be exempt from, or to comply with, the requirements of Section 409A of the Code, and the Plan
shall be interpreted and administered in a manner consistent with such intent. 

  

 5 

	V.	Plan Administration. 

  

	 	5.1	Operation and Administration of Plan by Administrator. The Administrator has complete authority to control and manage the operation and administration of the Plan. The
Administrator shall have full and exclusive discretionary authority to: 

  

	 	(a)	construe and interpret the provisions of the Plan; 

  

	 	(b)	adopt any rules, procedures, and forms that are necessary for the operation and administration of the Plan that are consistent with its provisions; 

  

	 	(c)	determine eligibility for and the amount of Severance Benefits or Supplemental Severance Benefits for any Employee, as well as all other questions relating to the eligibility,
benefits, and other rights of Employees under the Plan; 

  

	 	(d)	keep all records necessary for the operation and administration of the Plan; 

  

	 	(e)	designate or employ agents (who may also be employees of the Employer) and delegate to them the exercise of one or more specific powers of the Administrator; and, to the extent that
the exercise of such powers involves fiduciary responsibility, such agents will be fiduciaries of the Plan; and 

  

	 	(f)	retain any legal, accounting or other expert advisers (who may also be advisers to the Employer) in connection with the Administrator’s operation and administration of the
Plan. 

  

	 	5.2	Reliance on Documents, Instruments, Etc. The Administrator may rely on any certificate, statement or other representation that is made on behalf of the Employer or any
Employee that it believes, in good faith, to be genuine, and on any certificate, statement, report or other representation that is made to it by any agent or any attorney, accountant or other expert retained by it or the Employer in connection with
the operation and administration of the Plan. 

  

	 	5.3	Administrative Expenses. All expenses of operating and administering the Plan, including, but not limited to, fees of any agents and experts retained by the Administrator
under Section 5.2, will be paid by the Employer. 

  

	 	5.4	Bond, Compensation, Indemnification of Administrator. No bond or other security will be required of the Administrator, except as provided by law. No compensation will be paid
to any person for performing his or her duties as Administrator. The Administrator will be indemnified by the Employer for any liabilities (including legal expenses) arising from any act or failure to act that is done in good faith in accordance
with the Plan’s provisions. 

  

	 	5.5	More Than One Fiduciary Capacity. Person(s) may serve in more than one fiduciary capacity under the Plan. 

  

 6 

	 	5.6	Filing of Claims; Denial of Claims; Appeals. The Plan Administrator shall notify an eligible Employee of any severance pay and benefits the Employee is entitled to receive
under the Plan. Any claim arising under the Plan shall be filed with the Plan Administrator, in writing, within one year of the date of a Qualifying Termination. If any person (the “claimant”) claims payments under the Plan and the claim
is wholly or partially denied, the following procedures will apply to resolve it: 

  

	 	(a)	Within 90 days after the receipt of the claim, the Administrator will provide the claimant with written or electronic notice of its decision on the claim. If the Administrator
cannot render a decision on the claim within the 90-day period because of special circumstances, the Administrator may extend the period in which to render the decision by an additional 90 days, up to a total of 180 days after its receipt of the
written claim. The Administrator will provide the claimant with a written notice of any extension before the end of the initial 90-day period, which indicates the special circumstances that require the extension and the expected decision date. If
the claim is deemed denied in whole or in part (an “adverse benefit determination”), the written or electronic notice of the decision will inform the claimant of (i) the specific reasons for the adverse benefit determination;
(ii) the specific provisions of the Plan upon which the adverse benefit determination is based; (iii) any additional information or material that is necessary to perfect the claim and the reasons why such information or material is
necessary; and (iv) the right to request a review of the adverse benefit determination, the procedures for requesting such review, and the claimant’s right to bring a civil action under Section 502(a) of ERISA. If the claimant does
not receive notice of the Administrator’s decision within the 90-day (plus any extension) period, the claimant should consider the claim denied. 

  

	 	(b)	A claimant who wishes to use the Plan’s claim appeal procedure must notify the Administrator that he or she wishes to appeal within 60 days of receiving the
Administrator’s written or electronic notice of an adverse benefit determination. The claimant may review ail relevant documents relating to the claim, including the Plan document, and may submit issues and comments in writing. The
Administrator will undertake a full and fair review of the record of the appeal of the adverse benefit determination and prepare its decision. The Administrator will give the claimant written or electronic notice of the decision of the appeal within
60 days after the receipt of the claimant’s notice of appeal. If special circumstances require an extension of time for processing, the Administrator may be given 120 days after the receipt of the claimant’s notice of appeal to render its
decision. The Administrator will provide the claimant with a written notice of the extension, before the end of the 60-day period, which indicates the special circumstances that require the extension and the expected decision date. The written or
electronic notice of the decision of the appeal will be written in a manner calculated to be understood by the claimant and will include the specific reasons for the decision, specific references to any facts or any provisions of the Plan on which
the decision is based, and a statement regarding the claimant’s right to bring a civil action under Section 502(a) of ERISA. If the claimant does not 

  

 7 

 receive notice of the Administrator’s decision within the 60-day period (plus any extension), the
claim shall be deemed to be denied. The decision of the Administrator on review is binding on all parties, subject to any determination by a court in an action under Section 502(a) of ERISA. 
  

	 	(c)	A claimant cannot file an action under Section 502(a) of ERISA until he or she has exhausted these procedures. 

 IN WITNESS WHEREOF, the Company has caused this amended and restated Plan to be executed by its
duly authorized officer on this 13th day of August, 2007. 
  

			
	CME GROUP INC.
		
	By:	 	 

		
	Its:	 	 MD, OD

  

 8 

 Appendix A 
 SEVERANCE SCHEDULE FOR 
 QUALIFYING STANDARD TERMINATIONS 
 Severance Benefits and Supplemental Severance Benefits, as described below, are conditioned on and will only be paid after an eligible Employee (i) executes a
Release and Waiver as described in Section 4.4 (unless such agreement is waived in accordance with that Section), and such agreement (if applicable) becomes effective after the applicable waiting period, and (ii) is determined by the
Administrator to have satisfied all other conditions to receive benefits under this Plan and this Appendix A. 
  

	A.	Amount of Severance Pay. 

  

	 	1.	Eligible Employees 

 Severance Pay will equal two
(2) weeks of Base Salary per Year of Service, subject to a minimum of six (6) weeks of Base Salary and a maximum of 39 weeks of Base Salary. 
 For purposes of the foregoing calculation: 
 “Base Salary” means the annual base rate
of pay of an eligible Employee, as in effect on the date on which such Employee is notified of his or her Qualifying Standard Termination. 
 “Year of Service” means each 12-consecutive-month period, which is measured from an eligible Employee’s most recent date of hire. 
  

	B.	SupplementaI Severance Benefits. 

 Supplemental Severance Benefits awarded by the Administrator in its sole discretion pursuant to Section 3.2 may include any of the following: 
  

	 	1.	Continuation Coverage. Payment of part or all of the cost of Continuation Coverage for an eligible Employee for a specified period of time during the Severance Period.

  

	 	2.	Outplacement Services. Outplacement assistance through a firm selected by the Employer. 

  

	 	3.	Stock Options and Restricted Stock. Acceleration of the vesting of stock options and restricted stock held by the Employee, but only to the extent such stock options and
restricted stock would have vested had the Employee remained employed by the Employer throughout the Severance Period. 

  

 A-1 

 Appendix B 
 SEVERANCE SCHEDULE FOR 
 QUALIFYING MERGER TERMINATIONS 
 Severance Benefits and Supplemental Severance Benefits, as described below, are conditioned on and will only be paid after an eligible Employee (i) executes a
Release and Waiver as described in Section 4.4 (unless such agreement is waived in accordance with that Section), and such agreement (if applicable) becomes effective after the applicable waiting period, and (ii) is determined by the
Administrator to have satisfied all other conditions to receive benefits under this Plan and this Appendix B. 
  

	A.	Severance Pay. 

 Severance Pay will equal
twelve (12) weeks of Base Salary, plus two (2) weeks of Base Salary per Year of Service, subject to a maximum of 52 weeks of Base Salary. 
 For purposes of the foregoing calculation: 
 “Base Salary” means the annual base rate of pay of an eligible
Employee, as in effect on the date on which such Employee is notified of his or her Qualifying Merger Termination. 
 “Year of
Service” means each 12-consecutive-month period, which is measured from an eligible Employee’s most recent date of hire. 
  

	B.	Continuation Coverage. 

 An Employee will
receive the right to receive Continuation Coverage in accordance with the time periods set forth under federal COBRA law. Medical coverage will automatically cease as provided in the applicable plan based on an Employee’s Termination of
Employment date, unless such Employee timely elects such Continuation Coverage under COBRA. If an eligible Employee does not timely elect Continuation Coverage, such Employee will not be permitted to reinstate such coverage at a later date. All of
the terms and conditions of the Employer’s health plans shall be applicable to an eligible Employee receiving Continuation Coverage. Any Continuation Coverage shall be at the Employer’s cost until the end of the Severance Period or, if
earlier, nine (9) months from the Employee’s Termination of Employment. The Employee shall be responsible for the cost of any Continuation Coverage thereafter. 
  

	C.	Outplacement Services. 

 Outplacement
assistance will be offered through a firm selected by the Employer. 
  

	D.	Stock Options and Restricted Stock. 

 Acceleration of the vesting of stock options and restricted stock held by Employee, but only to the extent such stock options and restricted stock would have vested had the Employee remained employed by the Employer throughout the Severance
Period. 
  

 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]